Did the West Nile virus outbreak in Greece start in [LOCATION] in 2010, initially affect mainly rural populations, spread widely across mainland Greece, and cause several cases in horses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

West Nile Virus Outbreak in Greece: Historical and Epidemiological Facts

The West Nile virus outbreak in Greece started in Central Macedonia in 2010, initially affected mainly rural populations, has spread significantly to mainland Greece, and caused several documented cases in horses—making option E (All of the above) correct.

The 2010 Outbreak Epicenter and Timeline

The outbreak began in Central Macedonia, Northern Greece during summer 2010, with most cases concentrated around four rivers forming a large Delta in the Thessaloniki region 1, 2. This represented the first documented WNV epidemic in Greece, with 197 neuroinvasive disease cases and 262 total human cases reported, resulting in 33-35 deaths (17% case-fatality rate) 3, 4, 2.

The causative agent was identified as WNV lineage 2, obtained from Culex pipiens mosquitoes trapped in sites where encephalitis cases occurred 1. This strain showed highest homology to Hungarian and South African strains, suggesting a distinct European introduction separate from Russian lineage 2 strains 1.

Rural Population Impact

Rural residents were disproportionately affected, with a prevalence ratio of 8.2 (95% CI: 1.1-58.7) compared to urban populations 4. The seroprevalence study conducted after the 2010 epidemic revealed:

  • Overall weighted seropositivity of 5.8% (95% CI: 3.8-8.6) in the outbreak epicenter
  • Approximately 1 in 130 infected individuals developed neuroinvasive disease
  • Only 18% of infected individuals had clinical manifestations 4

Risk factors for infection reflected high mosquito exposure in rural agricultural settings, consistent with WNV transmission patterns in areas with rice production and flood irrigation 5.

Geographic Spread Across Mainland Greece

WNV has spread extensively beyond the initial outbreak zone. Following 2010, the virus established endemic transmission and expanded to new areas:

  • 2011: Continued circulation in Central Macedonia with surveillance detecting seroconverted chickens 1.5 months before human cases 6
  • 2012: Spread to Eastern Macedonia-Thrace with 18.1% seroprevalence in sentinel chickens 6
  • 2018: Major resurgence with cases peaking across Southern Europe 5
  • 2022: Third most intense season with 286 cases (184 neuroinvasive), primarily in northern and central Greece, representing 96% of cases in two regions 7

The virus has become a seasonal threat with cases recurring annually during transmission periods, demonstrating successful establishment in Greek ecosystems 6, 8.

Equine Cases Documentation

WNV caused severe disease in horses during the 2010 outbreak. Between August and September 2010,17 horses with neurological signs were confirmed infected with WNV in Central Macedonia 3. Key findings included:

  • High seroprevalence: 33% in the Thessaloniki regional unit
  • High fatality rate: 30% among infected horses
  • High neurological manifestation ratio: 19% of infections resulted in clinical neurological disease 3

The duration of WNV-specific IgM antibodies in clinically affected horses was relatively short (10-60 days; mean 44 days) 3. This represented the first documented WNV infection in horses with clinical manifestations in Greece, establishing that the lineage 2 strain responsible for the human epidemic was also highly pathogenic for horses 3.

Clinical Significance

The Greek outbreak demonstrated that WNV lineage 2 strains can cause severe illness comparable to lineage 1, with infection-to-clinical disease ratios similar to those previously documented for WNV lineage 1 4. Advanced age and history of heart disease were independently associated with death, with overall mortality approximately 10% but reaching 20% in individuals ≥70 years 2, 9.

The 2022 season confirmed ongoing WNV circulation with a variant strain clustering into the Central European subclade of WNV lineage 2, indicating continued viral evolution within Greece 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.